Moderna’s stock tumbles after reported leak of data for cancer vaccine

1 publisher first detected 5d ago 2% of 46 Health publishers

Headline as filed by MarketWatch.

Compare coverage — 1 report

Every publisher that filed on this event, earliest first, with each one's headline, summary, times and how long after the first report they filed.
Publisher	Headline	Summary	Published	Detected	Delay	Source	Status
MarketWatch	Moderna’s stock tumbles after reported leak of data for cancer vaccine	Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.	22 Oct, 18:10	22 Oct, 18:15	0m	marketwatch.com	First

Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.

Reader comments

Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.

Nobody has commented on this story yet.

Related coverage

connected by shared subjects

Moderna’s stock tumbles after reported leak of data for cancer vaccine

Compare coverage — 1 report

Reader comments

Add a comment

Related coverage

Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction

Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

The excitement around Moderna’s cancer vaccine is cooling. Here’s why.

New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

Primary 1 registration changes could cut Phase 2A places at some popular schools by a fifth or more